Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer.

From 2015-06-01 to 2017-05-31, ongoing project

Project details

Total cost:

EUR 4 244 969,25

EU contribution:

EUR 4 244 969

Coordinated in:

Sweden

Call for proposal:

H2020-SMEINST-2-2014See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Related information

Open Access

Coordinator

IMMUNOVIA AB
Sweden

EU contribution: EUR 4 244 969


MEDICON VILLAGE
223 81 LUND
Sweden
Record Number: 198097 / Last updated on: 2016-01-20